Clinical trial
SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00103311 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00103311 |
|---|---|
| Title | SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer |
| Official title | A Randomized Phase II Non-Comparative Study of SB-715992 Given Weekly or Every Three Weeks in Advanced or Metastatic Colorectal Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer and 2 more |
| Intervention type | Drug, Other |
| Interventions | ispinesib, laboratory biomarker analysis |
| Enrollment | 64 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Feb 8, 2005 |
| Last update posted | Mar 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: